Aspire Biopharma Provides Q3 2025 Business Update
Go back to Aspire Biopharma Provides Q3 2025 Business Update| (NASDAQ: ASBP) | Delayed: 8.88 +0.10 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.78 | 52 Week High | $ | |||
| Open | $8.67 | 52 Week Low | $ | |||
| Day High | $8.88 | P/E | N/A | |||
| Day Low | $8.40 | EPS | $ | |||
| Volume | 20,282 | |||||



